Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

ABSTRACT A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection caused by a carbapenem-resistant Klebsiella pneumoniae strain that typed to the sequence type 14 complex. The isolate, Klebsiella pneumoniae 05-506, was shown to possess a metallo-β-lactamase (MBL) but was negative for previously known MBL genes. Gene libraries and amplification of class 1 integrons revealed three resistance-conferring regions; the first contained blaCMY-4 flanked by ISEcP1 and blc. The second region of 4.8 kb contained a complex class 1 integron with the gene cassettes arr-2, a new erythromycin esterase gene; ereC; aadA1; and cmlA7. An intact ISCR1 element was shown to be downstream from the qac/sul genes. The third region consisted of a new MBL gene, designated blaNDM-1, flanked on one side by K. pneumoniae DNA and a truncated IS26 element on its other side. The last two regions lie adjacent to one another, and all three regions are found on a 180-kb region that is easily transferable to recipient strains and that confers resistance to all antibiotics except fluoroquinolones and colistin. NDM-1 shares very little identity with other MBLs, with the most similar MBLs being VIM-1/VIM-2, with which it has only 32.4% identity. As well as possessing unique residues near the active site, NDM-1 also has an additional insert between positions 162 and 166 not present in other MBLs. NDM-1 has a molecular mass of 28 kDa, is monomeric, and can hydrolyze all β-lactams except aztreonam. Compared to VIM-2, NDM-1 displays tighter binding to most cephalosporins, in particular, cefuroxime, cefotaxime, and cephalothin (cefalotin), and also to the penicillins. NDM-1 does not bind to the carbapenems as tightly as IMP-1 or VIM-2 and turns over the carbapenems at a rate similar to that of VIM-2. In addition to K. pneumoniae 05-506, blaNDM-1 was found on a 140-kb plasmid in an Escherichia coli strain isolated from the patient's feces, inferring the possibility of in vivo conjugation. The broad resistance carried on these plasmids is a further worrying development for India, which already has high levels of antibiotic resistance.

[1]  M. Botta,et al.  Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases. , 2009, Chemistry & biology.

[2]  P. Bennett,et al.  Common regions e.g. orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons. , 2006, The Journal of antimicrobial chemotherapy.

[3]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[4]  C. Tribuddharat,et al.  Integron-Mediated Rifampin Resistance inPseudomonas aeruginosa , 1999, Antimicrobial Agents and Chemotherapy.

[5]  Thierry Naas,et al.  Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France , 2000, Antimicrobial Agents and Chemotherapy.

[6]  A. Clarke,et al.  Novel mechanism of hydrolysis of therapeutic beta-lactams by Stenotrophomonas maltophilia L1 metallo-beta-lactamase. , 2001, The Journal of biological chemistry.

[7]  P. Nordmann,et al.  Carbapenemases: molecular diversity and clinical consequences. , 2007, Future microbiology.

[8]  A. Karabinis,et al.  VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases. , 2007, International journal of antimicrobial agents.

[9]  C. Zeana,et al.  Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. , 2006, American journal of infection control.

[10]  P. Nordmann,et al.  VIM-5 metallo-beta-lactamase-producing Pseudomonas putida from Turkey. , 2009, International journal of antimicrobial agents.

[11]  T. Walsh Clinically significant carbapenemases: an update , 2008, Current opinion in infectious diseases.

[12]  M. Toleman,et al.  Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. , 2008, The Journal of antimicrobial chemotherapy.

[13]  J. Campos,et al.  Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. , 2008, The Journal of antimicrobial chemotherapy.

[14]  J. Herrmann,et al.  Plasmid-Mediated Rifampin Resistance Encoded by anarr-2-Like Gene Cassette in Klebsiella pneumoniae Producing an ACC-1 Class C β-Lactamase , 2001, Antimicrobial Agents and Chemotherapy.

[15]  Ronald N. Jones,et al.  bla VIM-7, an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States , 2004, Antimicrobial Agents and Chemotherapy.

[16]  Ronald N. Jones,et al.  Biochemical Characterization of the Acquired Metallo-β-Lactamase SPM-1 from Pseudomonas aeruginosa , 2003, Antimicrobial Agents and Chemotherapy.

[17]  A. Vatopoulos High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  Sylvain Brisse,et al.  Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates , 2005, Journal of Clinical Microbiology.

[19]  P. Nordmann,et al.  Molecular Epidemiology of the Integron-Located VEB-1 Extended-Spectrum β-Lactamase in Nosocomial Enterobacterial Isolates in Bangkok, Thailand , 2001, Journal of Clinical Microbiology.

[20]  David L Paterson Resistance in gram-negative bacteria: enterobacteriaceae. , 2006, The American journal of medicine.

[21]  M. Roberts Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics , 2004, Molecular biotechnology.

[22]  A. Brisabois,et al.  Novel Plasmid-Encoded Ceftazidime-Hydrolyzing CTX-M-53 Extended-Spectrum β-Lactamase from Salmonella enterica Serotypes Westhampton and Senftenberg , 2009, Antimicrobial Agents and Chemotherapy.

[23]  M. Toleman,et al.  Evolution of the IS CR 3 Group of IS CR Elements , 2008 .

[24]  Amersham Pharmacia Biotech Plasmid-Mediated Rifampin Resistance Encoded by an arr-2-Like Gene Cassette in Klebsiella pneumoniae Producing an ACC-1 Class C -Lactamase , 2001 .

[25]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[26]  T. Kirikae,et al.  KHM-1, a Novel Plasmid-Mediated Metallo-β-Lactamase from a Citrobacter freundii Clinical Isolate , 2008, Antimicrobial Agents and Chemotherapy.

[27]  P. Bennett,et al.  ISCR Elements: Novel Gene-Capturing Systems of the 21st Century? , 2006, Microbiology and Molecular Biology Reviews.

[28]  M. Toleman,et al.  Evolution of the ISCR3 Group of ISCR Elements , 2008, Antimicrobial Agents and Chemotherapy.

[29]  M. Roberts,et al.  Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. , 2008, FEMS microbiology letters.

[30]  J. Jorgensen,et al.  KPC-2-Producing Enterobacter cloacae and Pseudomonas putida Coinfection in a Liver Transplant Recipient , 2008, Antimicrobial Agents and Chemotherapy.

[31]  Jane W. Marsh,et al.  Integron-mediated Multidrug Resistance in a Global Collection of Nontyphoidal Salmonella enterica Isolates , 2009, Emerging infectious diseases.

[32]  P. Nordmann,et al.  Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium , 2008, Antimicrobial Agents and Chemotherapy.

[33]  Thomas E. Besser,et al.  Variability in the Region Downstream of the blaCMY-2 β-Lactamase Gene in Escherichia coli and Salmonella enterica Plasmids , 2006, Antimicrobial Agents and Chemotherapy.

[34]  Moreno Galleni,et al.  Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.

[35]  A. Sundsfjord,et al.  Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. , 2009, The Journal of antimicrobial chemotherapy.

[36]  Ronald N. Jones,et al.  Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. , 2002, The Journal of antimicrobial chemotherapy.

[37]  D. S. Hammond,et al.  Selection of SHV Extended-Spectrum-β-Lactamase-Dependent Cefotaxime and Ceftazidime Resistance in Klebsiella pneumoniae Requires a Plasmid-Borne blaSHV Gene , 2007, Antimicrobial Agents and Chemotherapy.

[38]  M. Castanheira,et al.  Kinetic Characterization of VIM-7, a Divergent Member of the VIM Metallo-β-Lactamase Family , 2008, Antimicrobial Agents and Chemotherapy.

[39]  Timothy R. Walsh,et al.  Metallo-β-Lactamases: the Quiet before the Storm? , 2005, Clinical Microbiology Reviews.

[40]  A. Clarke,et al.  Novel Mechanism of Hydrolysis of Therapeutic β-Lactams byStenotrophomonas maltophilia L1 Metallo-β-lactamase* , 2001, The Journal of Biological Chemistry.

[41]  P. Nordmann,et al.  Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey , 2008, Antimicrobial Agents and Chemotherapy.

[42]  Alejandro J. Vila,et al.  Metallo-β-lactamases: Novel Weaponry for Antibiotic Resistance in Bacteria , 2006 .

[43]  F. Weill,et al.  Association of IS26-composite transposons and complex In4-type integrons generates novel multidrug resistance loci in Salmonella genomic island 1. , 2008, The Journal of antimicrobial chemotherapy.

[44]  O. Dideberg,et al.  The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form. , 2008, Journal of molecular biology.